Yiyi Zhu
Wenzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
fMRI-guided V1-targeted rTMS improves depressive symptoms in adolescents and young adults with bipolar disorder: a double-blind randomized controlled trial.
Journal: BMC medicine
Published: July 30, 2025
SKI-606, a Src inhibitor, ameliorates benzene-induced hematotoxicity via blocking ROS/Src kinase-mediated p38 and Akt signaling pathways.
Journal: Ecotoxicology and environmental safety
Published: August 15, 2024
The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders.
Journal: Neuropsychiatric disease and treatment
Published: November 06, 2022
Circulating T-cell subsets discrepancy between bipolar disorder and major depressive disorder during mood episodes: A naturalistic, retrospective study of 1015 cases.
Journal: CNS neuroscience & therapeutics
Published: July 25, 2022
Multi-omics analyses of serum metabolome, gut microbiome and brain function reveal dysregulated microbiota-gut-brain axis in bipolar depression.
Journal: Molecular psychiatry
Published: October 12, 2021
Metformin acts on the gut-brain axis to ameliorate antipsychotic-induced metabolic dysfunction.
Journal: Bioscience trends
Published: September 30, 2021
Impaired blood-brain barrier in the microbiota-gut-brain axis: Potential role of bipolar susceptibility gene TRANK1.
Journal: Journal of cellular and molecular medicine
Published: December 28, 2020
Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia.
Journal: Translational cancer research
Published: May 25, 2020
Benzene induces haematotoxicity by promoting deacetylation and autophagy.
Journal: Journal of cellular and molecular medicine
Published: July 14, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026